Loading clinical trials...
Loading clinical trials...
High-Flow Nasal Cannula Oxygen Therapy (HFNC) Alone or Associated With Noninvasive Ventilation (NIV) for Immunocompromised Patients Admitted to Intensive Care Unit for Acute Respiratory Failure : FLORALI-Immunodéprimés
Conditions
Interventions
NIV/HFNC
HFNC
Locations
1
France
CHU de Poitiers
Poitiers, France
Start Date
January 21, 2017
Primary Completion Date
April 2, 2019
Completion Date
August 30, 2019
Last Updated
September 4, 2019
NCT06694740
NCT05423301
NCT06750536
NCT06934876
NCT06972069
NCT02310867
Lead Sponsor
Poitiers University Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions